David Panush, MD
Professor of Medicine
Director, Scleroderma Program-RWJ Medical School
Program Director for the Rheumatology Fellowship Program
SO NOW WHAT?
BRAD HARRIS ROVIN, M.D.
Professor of Medicine and Pathology
Director, Division of Nephrology
Director, GN Fellowship Program
Medical Director, The Center for Clinical Research
Management
Ohio State University College of Medicine
Columbus, OH
BERNARD KIM, M.D.
Associate Director of The Heart Failure and Pulmonary
Hypertension Program
Hackensack University Medical Center
Bergen County, NJ
Core Assistant Professor- Department of Cardiology
Department of Internal Medicine
Hackensack Meridian Health School of Medicine
WHAT IS THE REFFERING OPHTALMOLOGIST
TALKING ABOUT?
DAVID SHU-CHIH CHU, M.D.
Associate Professor of Clinical Ophthalmology Rutgers, New
Jersey Medical School Institute Ophthalmology & Visual
Science
Attending Physician, University Hospital, Newark, NJ.
East Orange Veterans Affairs Medical Center
Hackensack University Medical Center
2021 Annual Spring Meeting was held Thursday May 20, 2021
Pemphigus vulgaris—diagnosis and management
Jacob O Levitt, MD
Mt Sinai Hospital
Osteoporosis, 2021: an update
John P Bilezikian, MD
NY Presbyterian
It’s Covid-19 as immunology bootcamp
Leonard Henry Calabrese, DO
Cleveland Clinic
Therapeutic advancements in ANCA-associated vasculitis: No more prednisone?
Rennie Rhee, MD, MSCE
University of Pennsylvania
Due to the COVID-19 epidemic the meeting was held virtually.
Link for recorded program:
2020: Virtual meeting was held Thursday, May 21, 2020
Use the link below to view the meeting.
Schedule:
8:45 am Welcome NJRA members & tribute to Linda Bartolo
9 am Dr. Richard Loeser Jr.: Osteoarthritis and disease modification: Where are we?
10 am Dr. Janice Mehnert: Rheumatologic toxicities from immune checkpoint inhibitors
11 am Dr. Ann Rosenthal: The world of CPPD crystals to 2020
Noon: Dr. Rula Jajj-Ali : CNS vasculitis and its imposters
1-2 pm NJRA business discussion/wrap up
GOALS: To update and educate our membership on state of the art topics in Rheumatology and to promote better patient awareness.
LEARNING OBJECTIVES: Upon completion of the program participants should be able to:
• Review the latest in pathophysiology of osteoarthritis and gain insight into potential therapeutic strategies that may be disease modifying.
• Identify the rheumatic diseases that may develop from use of Immune Checkpoint Inhibitors (ICI) and their outcomes in population with cancer.
• Review pathophysiology of calcium pyrophosphate crystal deposition (CPPD) and potential therapeutic targets.
• Describe mimics of CNS vasculitis, review cases, and advances in diagnostic tools and management.
TARGET AUDIENCE: Rheumatologists, Attending Physicians. Fellows, Residents, Medical Students, and Allied Health Professionals are welcome to attend.